Jose Medina, accused of fatally shooting a Chicago college student, was hospitalized for tuberculosis treatment and missed his first court appearance.
NYC health officials confirmed the first known case of mpox clade I in a person who had recently traveled internationally.
FBI seeks Pennsylvania woman who allegedly faked brain cancer diagnosis to defraud friends and family of thousands of dollars for personal vacations.
A 22-year-old bodybuilding influencer died under suspicious circumstances while a 40-year-old wellness coach died after participating in a detox ritual.
Nine people, including children, have been sickened in an E. coli outbreak connected to raw milk and cheese from a California company.
A federal judge temporarily halted Health Secretary Robert F. Kennedy Jr.'s cuts to childhood vaccine recommendations and his reconstitution of a key advisory committee.
Uganda closed its western border with Congo due to Ebola fears, stranding cargo trucks and causing significant economic losses for cross-border traders.
A fourth case of meningitis has been confirmed at a junior school in Reading, with health authorities saying all cases are linked to the same social network.
Hayam El Gamal was taken to emergency room after detention center allegedly delayed CT scan for weeks despite chest symptoms.
The U.S. Department of Defense will fund studies testing MDMA-assisted therapy for 186 active-duty service members with PTSD.
Pharmaceutical giant Eli Lilly announced plans to acquire Centessa Pharmaceuticals, which develops experimental sleep disorder treatments, in a deal valued at up to $7.8 billion.
Researchers found that brief dietary modifications, particularly plant-based diets, may reduce biological age markers in older adults within four weeks.
Research suggests GLP-1 drugs like Ozempic may help treat alcohol use disorder, while companies report increased gum and mint sales linked to the medications.
Novo Nordisk introduces multi-month subscription program offering discounted Wegovy weight-loss medication to uninsured patients in the United States.
The dangerous synthetic opioid carfentanil is experiencing a resurgence in the US drug supply, leading to hundreds of overdoses.
Page 22 of 42 (620 stories)